Dilated Cardiomyopathy Type 1G — A Silent Threat Uncovered
Note: Real cases, names and ages have been changed for privacy.
The Family
Elena and Chris had a family history of heart disease but no known diagnoses. Their pediatrician recommended Fore Genomics screening for their son, Leo.
The Genetic Finding
Leo’s test showed a mutation in the TTN gene, linked to Dilated Cardiomyopathy Type 1G (DCM1G). This condition causes the heart to enlarge and weaken over time, often without symptoms until a dangerous heart event occurs.
The Impact
- Leo underwent baseline cardiac imaging at age 1, which was normal.
- He now has annual heart checks.
- The same mutation was later found in Chris (his father), who had never been tested.
Chris was stunned to learn he carried the same condition and grateful his son’s test may have saved them both.Today, both father and son are under monitoring, with lifestyle changes and medical oversight reducing their risk of heart failure.
Why It Matters
Without this insight, Leo’s first sign of illness could have come far too late. Now, his family has time and options.
Final Takeaway
Genetic screening is not about fear — it’s about preparation. These case studies show how insights from DNA can:
- Prevent emergencies
- Enable early treatment
- Guide lifelong health decisions